Answers are grounded in this paper and cite their sources.
Several lines of evidence indicate that cholecystokinin (CCK) antagonists potentiate analgesia induced by exogenous opioids. Similarly, CCK antagonists enhance analgesia induced by procedures that activate endogenous opioid systems. However, because there are substantial species differences in receptor specificity and distribution, the role of CCK type A and type B receptors has yet to be clearly established.
No takes yet. Share an insight, caveat, or question.
Fabrizio Benedetti (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: